CytomX Therapeutics, Inc. (CTMX) Financial Statements (2024 and earlier)

Company Profile

Business Address 151 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:95,574266,349256,298296,145436,127374,110
Cash and cash equivalents193,650205,530191,859188,425247,577177,548
Short-term investments 99,696124,260107,720188,550196,562
Other undisclosed cash, cash equivalents, and short-term investments(98,076)(38,877)(59,821)   
Receivables35,986790798139710,139
Other undisclosed current assets105,54243,16266,9177,1779,2514,352
Total current assets:237,102310,301324,013303,335445,475388,601
Noncurrent Assets
Operating lease, right-of-use asset15,94919,36222,49525,382
Property, plant and equipment5,0725,9606,9507,3726,9344,218
Intangible assets, net (including goodwill)1,8241,9702,1162,2612,4072,553
Goodwill949949949949949949
Intangible assets, net (excluding goodwill)8751,0211,1671,3121,4581,604
Restricted cash and investments917917917917917917
Other noncurrent assets279012,1722,0151,3751,355
Total noncurrent assets:23,78929,11034,65037,94711,6339,043
TOTAL ASSETS:260,891339,411358,663341,282457,108397,644
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities31,34137,05426,05534,20945,19520,588
Taxes payable   13,339 
Accounts payable2,8092,8182,9964,1585,1324,205
Accrued liabilities28,53234,23623,05930,05126,72416,383
Deferred revenue121,26740,81674,86951,381
Deferred revenue and credits40,559
Contract with customer, liability52,713
Total current liabilities:152,60877,870100,92485,59097,90861,147
Noncurrent Liabilities
Long-term debt and lease obligation:   21,67524,871  
Liabilities, other than long-term debt194,034262,000186,261179,708228,317266,601
Deferred revenue and credits264,704
Deferred revenue180,059243,944186,261178,858
Contract with customer, liability225,267
Other liabilities   8503,0501,897
Operating lease, liability13,97518,05621,67524,871
Total noncurrent liabilities:194,034262,000207,936204,579228,317266,601
Total liabilities:346,642339,870308,860290,169326,225327,748
Equity
Equity, attributable to parent(85,751)(459)49,80351,113130,88369,896
Common stock111111
Additional paid in capital637,117623,344499,964468,285445,956289,454
Accumulated other comprehensive income (loss)10(242)(47)57(93)(94)
Accumulated deficit(722,879)(623,562)(450,115)(417,230)(314,981)(219,465)
Total equity:(85,751)(459)49,80351,113130,88369,896
TOTAL LIABILITIES AND EQUITY:260,891339,411358,663341,282457,108397,644

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues53,16337,312100,36257,48959,50271,623
Revenue, net71,623
Gross profit:53,16337,312100,36257,48959,50271,623
Operating expenses(154,498)(153,354)(148,967)(168,384)(137,376)(117,882)
Operating loss:(101,335)(116,042)(48,605)(110,895)(77,874)(46,259)
Nonoperating income2,0181721,8098,2307,5732,647
Investment income, nonoperating1,6782551,8368,3657,6412,674
Other nonoperating income (expense)340(83)(27)(135)(68)(27)
Loss from continuing operations before income taxes:(99,317)(115,870)(46,796)(102,665)(70,301)(43,612)
Income tax expense (benefit)  13,911427(14,303)513
Loss from continuing operations:(99,317)(115,870)(32,885)(102,238)(84,604)(43,099)
Loss before gain (loss) on sale of properties:(32,885)(102,238)(84,604)(43,099)
Net loss available to common stockholders, diluted:(99,317)(115,870)(32,885)(102,238)(84,604)(43,099)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(99,317)(115,870)(32,885)(102,238)(84,604)(43,099)
Other comprehensive income (loss)     1(67)
Comprehensive loss:(99,317)(115,870)(32,885)(102,238)(84,603)(43,166)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent252(195)(104)150  
Comprehensive loss, net of tax, attributable to parent:(99,065)(116,065)(32,989)(102,088)(84,603)(43,166)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: